Effect of selenium supplementation on biochemical markers and outcome in critically ill patients

Clinical Nutrition

Volumn 26, Issue 1, 2007, Pages 41-50

  Mishra, Vinita ^a   Baines, Malcolm ^a   Elizabeth Perry, Sara ^a   Jeremy McLaughlin, Paul ^a   Carson, Jeff ^a   Wenstone, Richard ^a   Shenkin, Alan ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

F2 isoprostanes; F2IsoP; Glutathione peroxidase; GSH Px; Intensive care unit (ICU); Sepsis; SIRS; Systemic inflammatory response syndrome

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; ISOPROSTANE; LIOTHYRONINE; PLACEBO; SELENIUM; SODIUM SELENITE; THYROXINE;

AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ENTEROBACTER; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MALE; MEDICAL ASSESSMENT; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPSIS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; THYROID FUNCTION; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INTENSIVE CARE UNITS; KIDNEY; MALE; MULTIPLE ORGAN FAILURE; NUTRITIONAL REQUIREMENTS; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SELENIUM; SEPSIS; SEVERITY OF ILLNESS INDEX; THYROID GLAND; TREATMENT OUTCOME;

EID: 33846587450     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.10.003     Document Type: Article

References (33)

1. Balk R.A., and Bone R.C. The septic syndrome: Definition and clinical implications. Crit Care Clin 5 (1989) 1-8
2. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
3. Brown K.M., and Arthur J.R. Selenium, selenoproteins and human health: a review. Public Health Nutr 4 2B (2001) 593-599
4. Arthur J.R. The glutathione peroxidases. Cell Mol Life Sci 57 (2000) 1825-1835
5. Arthur J.R., and Beckett G.J. Selenium and endocrine systems. J Endocrinol 184 (2005) 455-465
6. Harrison I., Littlejohn D., and Fell G.S. Distribution of selenium in human blood and plasma and serum. Analyst 121 2 (1996) 189-194
7. Kohrle J. The deiodinase family: selenoenzymes regulating thyroid hormone availability andaction. Cell Mol Life Sci 57 (2000) 1853-1863
8. Arthur J.R., Mckenzie R.C., and Beckett G.C. Selenium in the immune system. Am Soc Nutr Sci (2003) 457S-459S
9. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., and Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-kappa β activation and neutrophilic lung inflammation. J Immunol 157 (1996) 1630-1637
10. Brown K.M., Pickard K., Nicol F., Beckett G.J., Duthie G.G., and Arthur J.R. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin Sci 98 (2000) 593-599
11. Hawker F.H., Stewart P.M., and Snitch P.J. Effects of acute illness on selenium homeostasis. Crit Care Med 18 (1990) 442-446
12. Forceville X., Vitoux D., Gauzit R., Combes A., Lahilaire P., and Chappuis P. Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med 26 (1998) 1536-1544
13. Berger M.M., Cavadini C., Bart A., Blondel A., Bartholdi I., and Vandervale A. Selenium losses in 10 burned patients. Clin Nutr 11 (1992) 75-82
14. Kuklinski B., Zimmermann T., and Schweder R. Letalitatssenkung der akuten pancreatitis mit Na-selenit: klinische resultate einer vierjahrigen antioxidanzientherapie. Med Klin 90 (1995) 36-41
15. Zimmermann T., Albrecht S., Kuhne H., Vogelsang U., Grutzmann R., and Kopprasch S. Selensubstitution bei sepsis-patienten. Med Klin 92 Suppl III (1997) 3-4
16. Angstwurm M.W.A., Schottdorf J., Schopohl J., and Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27 (1999) 1807-1813
17. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
18. Kanous A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHEII: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
19. Vincent J.-L., Moreno R., Takala J., Willatts S., Mendonca A., and Bruining H. The SOFA (sepsis related organ failure assessment). Intens Care Med 22 (1996) 707-710
20. Moreno R., Vincent J.L., Matos R., Mendonca A., Cantraine F., and Thijs L. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related problems of the ESICM. Intens Care Med 25 (1999) 686-696
21. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., and Roberts II L.J. Non-cyclooxygenase derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89 (1992) 10721-10725
22. Shenkin A., Baines M., Fell G.S., and Lyon T.D.G. Vitamins and trace elements. In: Burtis C.A., Ashwood E.R., and Bruns D.E. (Eds). Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed (2006), Elsevier Saunders, St Louis, MI
23. Levey S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
24. Nichol C., Herdman J., Sattar N., O'Dwyer P.J., O'Reilly S.J., Littlejohn D., and Fell G. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: Further evidence for a negative acute phase response?. Clin Chem 44 8 (1998) 1764-1766
25. Berger M.M., Baines M., Chiolero R.L., Wardle C.A., Cayeux C., and Shenkin A. Influence of early trace element and vitamin E supplements on antioxidant status after major trauma: a controlled trial. Nutr Res 21 (2001) 41-54
26. Spallholz J.E. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 10 (1997) 260-270
27. Terada A., Yoshida M., Seko Y., Kobayashi T., and Yoshida K. Active oxygen species generation and cellular damage by additives of parenteral preparations: Selenium and sulphydryl compounds. Nutrition 15 (1999) 651-655
28. Cracowski J.L., Durand T., and Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinicalimplications (review). Trends Pharmacol Sci 23 (2002) 360-366
29. Basu S., and Helmersson J. Factors regulating isoprostane formation in vivo (review). Antioxid Redox Signal 7 (2005) 221-235
30. Roth E., Manhart N., and Wessner B. Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 7 2 (2004) 161-168
31. Bermudez F., Surks M.I., and Oppenheimer J.H. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 39 (1974) 501-511
32. Avenell A., Noble D.W., Barr J., and Engelhardt T. Selenium supplementation for critically ill adults (review). Cochrane Library 1 (2005) 1-18
33. Heyland D.K., Dhaliwal R., Suchner U., and Berger M.M. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intens Care Med 31 (2005) 327-337